May 2016 |
|
Wyden Statement at Finance Committee Hearing on Corporate Integration
|
|
Wyden Raises Dangers of Powerful Opioid Fentanyl
|
|
Wyden and Murray Call for Action to Improve Health Data Transparency
|
|
Wyden Unveils Tax Proposal to Build a Fairer System
|
|
Wyden Statement at Finance Committee Hearing on Corporate Integration
|
|
Wyden and Murray Statement on House GOP Suit on ACA Cost-Sharing Subsidies
|
|
Wyden Statement at Finance Committee Nominations Hearing
|
|
Wyden Statement at Finance Committee Hearing on Trade Enforcement
|
|
Wyden Statement at Finance Committee Hearing on Evidence-Based Policymaking for Social Welfare Programs
|
|
Wyden Probes Into Anonymous Shell Companies with Ties to Mossack Fonseca in Nevada and Wyoming
|
|
Wyden Statement on USTR Action Against China’s Poultry Tariffs
|
|
Wyden Encouraged by Treasury Action to Improve Financial Transparency
|
|
Wyden Relieved By Rejection of Proposed Pension Cuts By Treasury Department
|
|
Wyden Cheers Decision to Regulate E-Cigarettes as a Tobacco Product
|
April 2016 |
|
Wyden Calls for Crackdown on Corporate Tax Gap
|
|
Finance Democrats Outline Concerns with Medicare Part B Demo
|
|
Wyden Proposes Cap on Prescription Drug Costs
|
|
Wyden Proposes Simplifying Capital Depreciation Rules
|
|
Wyden Statement at Finance Hearing on Business Tax Reform
|
|
Wyden Calls for Robust Taxpayer Protections from Identity Theft and Tax Refund Fraud
|